Búsqueda | Biblioteca Virtual en Salud

1.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa, S; Troyanov, Y; Fritzler, M J; Targoff, I N; Chartrand, S; Mansour, A M; Rich, E; Boudabbouz, H; Bourré-Tessier, J; Albert, M; Goulet, J R; Landry, M; Senécal, J L.

Scand J Rheumatol ; 47(3): 210-224, 2018 05.

Artículo en Inglés | MEDLINE | ID: mdl-29065773

2.

Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.

Miller, L; Chartrand, S; Koenig, M; Goulet, J-R; Rich, É; Chin, A S; Chartrand-Lefebvre, C; Abrahamowicz, M; Senécal, J-L; Grodzicky, T.

Scand J Rheumatol ; 43(4): 314-23, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25089008

3.

Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.

Stutman, H R; Shalit, I; Marks, M I; Greenwood, R; Chartrand, S A; Hilman, B C.

Am J Med ; 82(4A): 142-5, 1987 Apr 27.

Artículo en Inglés | MEDLINE | ID: mdl-3555028

4.

Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.

Shalit, I; Stutman, H R; Marks, M I; Chartrand, S A; Hilman, B C.

Am J Med ; 82(4A): 189-95, 1987 Apr 27.

Artículo en Inglés | MEDLINE | ID: mdl-3555035

5.

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.

Bernstein, H H; Rothstein, E P; Watson, B M; Reisinger, K S; Blatter, M M; Wellman, C O; Chartrand, S A; Cho, I; Ngai, A; White, C J.

Pediatrics ; 92(6): 833-7, 1993 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-8233746

6.

Con A-induced suppressor cells in man. I. Introduction and characterization of suppressor cells.

Mizerski, J; Chartrand, S; Gajl-Peczalska, K.

Immunobiology ; 158(3): 270-81, 1981.

Artículo en Inglés | MEDLINE | ID: mdl-6452403

7.

Safety and toxicity profile of aztreonam.

Chartrand, S A.

Pediatr Infect Dis J ; 8(9 Suppl): S120-3; discussion S128-32, 1989 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-2682511

8.

Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children.

Harrison, C J; Chartrand, S A; Pichichero, M E.

Pediatr Infect Dis J ; 12(1): 62-9, 1993 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8417428

9.

Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies.

Still, J G; Hubbard, W C; Poole, J M; Sheaffer, C I; Chartrand, S; Jacobs, R.

Pediatr Infect Dis J ; 12(12 Suppl 3): S134-41, 1993 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-8295815

10.

Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center.

Boken, D J; Chartrand, S A; Goering, R V; Kruger, R; Harrison, C J.

Pediatr Infect Dis J ; 14(10): 879-84, 1995 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-8584316

11.

Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers.

Boken, D J; Chartrand, S A; Moland, E S; Goering, R V.

Pediatr Infect Dis J ; 15(8): 667-72, 1996 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-8858669

12.

Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.

Block, S L; Harrison, C J; Hedrick, J A; Tyler, R D; Smith, R A; Keegan, E; Chartrand, S A.

Pediatr Infect Dis J ; 14(9): 751-9, 1995 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-8559623

13.

Long-term assessment of renal function under cyclosporine in pediatric heart transplant recipients.

Robitaille, P; Chartrand, S; Stanley, P; Chartrand, C.

J Heart Lung Transplant ; 10(3): 460-2; discussion 463, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1854774

14.

Growth and pubertal development following pediatric heart transplantation: a 15-year experience at Ste-Justine Hospital.

de Broux, E; Huot, C H; Chartrand, S; Vobecky, S; Chartrand, C.

J Heart Lung Transplant ; 19(9): 825-33, 2000 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-11008070

15.

Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

Black, J; Moland, E S; Chartrand, S A; Thomson, K S.

Diagn Microbiol Infect Dis ; 39(3): 195-7, 2001 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-11337189

16.

Activity of faropenem against resistant isolates of Streptococcus pneumoniae.

Black, J A; Moland, E S; Chartrand, S A; Thomson, K S.

Diagn Microbiol Infect Dis ; 41(1-2): 89-92, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11687320

17.

Immunolocalization of extracellular matrix components during organogenesis in the human small intestine.

Beaulieu, J F; Vachon, P H; Chartrand, S.

Anat Embryol (Berl) ; 183(4): 363-9, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1714254

18.

Characterization of polymorphonuclear leukocyte aggregation in vitro induced by heat-inactivated group B streptococcus.

Panus, P C; Longenecker, G L; Chartrand, S A; Boerth, R C; Peevy, K J.

Inflammation ; 11(1): 87-93, 1987 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3552979

19.

In vitro inhibition of group B streptococcus-induced polymorphonuclear leukocyte aggregation.

Panus, P C; Longenecker, G L; Jones, H P; Chartrand, S A; Peevy, K J.

Inflammation ; 11(1): 111-5, 1987 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3032792

20.

Varicella vaccine.